GSK2881078
GSK2881078[edit | edit source]
GSK2881078 is a selective androgen receptor modulator (SARM) developed by GlaxoSmithKline. It is designed to mimic the effects of androgens in the body, which are hormones that play a role in male traits and reproductive activity. SARMs like GSK2881078 are of interest for their potential to treat conditions such as muscle wasting and osteoporosis without the side effects associated with traditional anabolic steroids.
Mechanism of Action[edit | edit source]
GSK2881078 works by selectively binding to the androgen receptors in the body. Unlike traditional androgens, which can affect many tissues, SARMs like GSK2881078 are designed to target specific tissues such as muscle and bone, potentially reducing unwanted side effects. This selectivity is achieved through the unique chemical structure of GSK2881078, which allows it to interact with the androgen receptor in a way that is different from natural androgens.
Potential Applications[edit | edit source]
The primary potential application of GSK2881078 is in the treatment of muscle wasting conditions, such as those associated with cancer, chronic obstructive pulmonary disease (COPD), and aging. By promoting muscle growth and strength, GSK2881078 could help improve the quality of life for patients suffering from these conditions.
Additionally, GSK2881078 may have applications in treating osteoporosis, a condition characterized by weak and brittle bones. By stimulating bone growth and increasing bone density, GSK2881078 could help reduce the risk of fractures in individuals with osteoporosis.
Development and Research[edit | edit source]
GSK2881078 is currently in the research and development phase, with studies focusing on its efficacy and safety profile. Clinical trials are necessary to determine the appropriate dosing, potential side effects, and long-term impacts of the drug. The development of SARMs like GSK2881078 represents a significant advancement in the field of endocrinology and pharmacology, offering new hope for patients with conditions that currently have limited treatment options.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
